Has Asim Pati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $323,737 in general payments to Asim Pati, MD across 1,027 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asim Pati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asim Pati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asim Pati, MD

Hematology · Spartanburg, SCNPI 1841294121

Payments from drug & device makers

$323,737in general payments, 2019–2025

Across 1,027 payments — averaging $315.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$166K
Bristol Myers Squibb$68K
Pharmacyclics LLC, An Abbvie Company$28K
Astrazeneca UK Limited$23K
E.r. Squibb & Sons, L.L.C.$9K
AstraZeneca$6K
plus $23K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	127	$166,375
Bristol Myers Squibb	70	$67,917
Pharmacyclics LLC, An Abbvie Company	153	$28,226
Astrazeneca UK Limited	2	$22,550
E.r. Squibb & Sons, L.L.C.	54	$9,196
AstraZeneca(2 entities)	50	$5,978
Sanofi	29	$5,324
Beigene USA, Inc.	11	$2,039
Servier Pharmaceuticals LLC	7	$1,872
Gilead(2 entities)	12	$1,615
AbbVie	19	$1,483
Janssen Research & Development, LLC	4	$1,264
Eisai Inc.	37	$789
Johnson & Johnson(2 entities)	45	$789
Genentech USA, Inc.	44	$695
Pfizer	42	$686
Merck	30	$619
Novartis	26	$543
Beigene, Ltd.	1	$450
Daiichi Sankyo Inc.	20	$448
Takeda Pharmaceuticals U.S.A., Inc.	15	$389
Seagen Inc.	19	$376
Astellas Pharma US Inc	12	$282
Ipsen Biopharmaceuticals, Inc	14	$245
Amgen	13	$239
Taiho Oncology, Inc.	12	$227
GSK	12	$214
Sobi, Inc	11	$191
AVEO Pharmaceuticals, Inc.	5	$180
Array Biopharma Inc	12	$174
Karyopharm Therapeutics Inc.	9	$164
Exelixis Inc.	8	$154
Lilly USA, LLC	9	$154
Kyowa Kirin, Inc.	4	$152
Regeneron Healthcare Solutions, Inc.	6	$141
Bayer	7	$131
Jazz Pharmaceuticals Inc.	6	$129
Beone Medicines USA, Inc.	5	$111
Rigel Pharmaceuticals, Inc.	6	$105
Pharmaessentia USA Corporation	5	$102
Boehringer Ingelheim	4	$98
G1 Therapeutics, Inc.	4	$85
AMAG Pharmaceuticals, Inc.	5	$74
ADC Therapeutics America, Inc.	4	$63
Adaptive Biotechnologies Corporation	3	$60
Coherus Oncology, Inc.	2	$56
Mirati Therapeutics, Inc.	2	$51
Stemline Therapeutics Inc.	2	$48
Deciphera Pharmaceuticals Inc.	2	$47
Epizyme, Inc.	2	$47
Geron Corporation	2	$45
Sirtex Medical Inc	3	$33
Tersera Therapeutics LLC	2	$31
Secura Bio, Inc.	2	$31
EMD Serono, Inc.	2	$30
Legend Biotech USA Inc.	1	$28
Lexicon Pharmaceuticals, Inc.	2	$25
CTI Biopharma Corp.	1	$22
Azurity Pharmaceuticals, Inc.	1	$22
Tesaro, Inc.	1	$20

How this compares

Too few hematology providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$93,323

Medicare patients

399

Services billed

1,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Spartanburg

Praneeth BaratamCharleston$1.9M
Sharif KhanGreenville$1.7M
Brian HessCharleston$1.3M
Hamza HashmiCharleston$694K
Benjamin DjulbegovicCharleston$225K
Christopher RangelCharleston$152K
Charles GreenbergCharleston$26K
Jailan OsmanColumbia$440
Samuel SmithGreenville$15

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →